Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Bristol-Myers Squibb reported $7.51B in Cash and Equivalent for its fiscal quarter ending in September of 2023.

Cash And Equivalent Change Date
ALKERMES USD 647.71M 18.08M Sep/2023
Amgen USD 34.74B 493M Sep/2023
AstraZeneca USD 4.87B 793M Sep/2023
Biogen USD 2.29B 329.9M Sep/2023
Bristol-Myers Squibb USD 7.51B 858M Sep/2023
Catalent USD 209M 71M Sep/2023
Eli Lilly USD 2.38B 313.7M Sep/2023
Gilead Sciences USD 5.7B 1000K Sep/2023
GlaxoSmithKline GBP 3.18B 37M Sep/2023
Perrigo USD 598.3M 43.1M Sep/2023
Phibro Animal Health USD 43.15M 1.87M Sep/2023
Prestige Brands USD 60.07M 5.49M Sep/2023
Regeneron Pharmaceuticals USD 2.15B 215.1M Sep/2023
Revance Therapeutics USD 179.32M 38.08M Sep/2023
Roche Holding CHF 3.72B 1.27B Jun/2023
United Therapeutics USD 1.11B 40.4M Sep/2023
Zoetis USD 1.75B 37M Sep/2023